 TORONTO, Dec. 22, 2020 GLOBE NEWSWIRE -- Venus Concept Inc. Venus Concept or the Company Nasdaq: VERO, a global medical aesthetic technology leader, today announced the pricing of its public offering of 11,250,000 shares of its common stock and warrants to purchase 5,625,000 shares of common stock at a combined offering price to the public of 2.00 per share and accompanying warrant. The warrants have an exercise price of 2.50 per share of common stock, are exercisable immediately, and expire five years from the date of issuance. Venus Concept intends to use the gross proceeds of approximately 22.5 million, before deducting underwriting discounts and commissions and estimated offering expenses, from the offering for general corporate purposes, including the funding of research and development activities. 